Helicobacter Pylori Infection

Helicobacter pylori (H. pylori) is a Gram-negative, spiral-shaped bacterium that has adapted to survive in the harsh acidic environment of the human stomach. H. pylori remains one of the most common chronic bacterial infections of humans worldwide.1

It is the leading cause of infection-associated cancer globally  and is categorized by the World Health Organization (WHO) as a group I carcinogen because of its causal association with gastric cancer.1

Evidence suggested a potential role of H. pylori infection in the pathophysiology of irritable bowel syndrome (IBS), a functional gastrointestinal disorder, that has a significant impact on the quality of life.2 All individuals who do not spontaneously clear the infection will develop chronic gastritis. Most infected individuals will remain asymptomatic and develop no meaningful clinical consequences.1

  • 0%

    global prevalence of H. pylori infection in adults.3

  • 0%

    global prevalence of H. pylori infection in children and adolescents.3

Factors affecting the prevalence of H. pylori infection are age, ethnicity, and socioeconomic status. Several external factors, including food, carcinogen exposure, excessive alcohol consumption, and tobacco, can contribute to H. pylori development.4

The possible routes of transmission are fecal–oral, oral–oral, and gastric–oral routes. Children became infected with H. pylori at a very young age. Intrafamilial clustering of H. pylori infection implied person-to-person transmission or common exposure to same contaminated source.

H. pylori prevalence gradually increased with age from adolescents (10%–30%) to the elderly (40%–60%) and also varied between ethnic groups.5

How to prevent health burden?

The greatest gift you can give yourself and your loved ones is a healthy you. Take care of your body and focus on living the highest quality of life you can through your daily choices.

At Acino, we have longstanding knowledge which we want to share with you. Explore our materials to raise your awareness, and make decisions to stay healthy and improve your quality of life.


 

H. pylori: Helicobacter pylori

IBS: irritable bowel syndrome

NSAID – nonsteroidal anti-inflammatory drug

 

References

  1. Chey, William D. MD, FACG1; Howden, Colin W. MD, FACG2; Moss, Steven F. MD, FACG3; Morgan, Douglas R. MD, MPH, FACG4; Greer, Katarina B. MD, MSEpi5; Grover, Shilpa MD, MPH6; Shah, Shailja C. MD, MPH7. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. The American Journal of Gastroenterology 119(9):p 1730-1753, September 2024. | DOI: 10.14309/ajg.0000000000002968
  2. Chunmei Wang, Yue Yin, Le Wang, Xiaozhong Guo, Lu Liu, Xingshun Qi, Association between Helicobacter pylori infection and irritable bowel syndrome: a systematic review and meta-analysis, Postgraduate Medical Journal, Volume 99, Issue 1169, March 2023, Available at: Pages 166–175, https://doi.org/10.1136/postgradmedj-2021-141127.
  3. Chen YC, Malfertheiner P, Yu HT, et al. Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022 [published correction appears in Gastroenterology. 2025 Apr;168(4):850. doi: 10.1053/j.gastro.2025.01.008.]. Gastroenterology. 2024;166(4):605-619. doi:10.1053/j.gastro.2023.12.022
  4. Elbehiry A, Marzouk E, Aldubaib M, et al. Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges. Antibiotics (Basel). 2023;12(2):191. Published 2023 Jan 17. doi:10.3390/antibiotics12020191
  5. Aumpan N, Mahachai V, Vilaichone RK. Management of Helicobacter pylori infection. JGH Open. 2022;7(1):3-15. Published 2022 Nov 21. doi:10.1002/jgh3.12843
  6. Bashir, Samina Khan, Khan, Muhammad Bashir, Overview of Helicobacter pylori Infection, Prevalence, Risk Factors, and Its Prevention, Advanced Gut & Microbiome Research, 2023, 9747027, 9 pages, 2023. https://doi.org/10.1155/2023/9747027
  7. Helicobacter pylori in children. Johns Hopkins Health Plans. Available at https://johnshopkinshealthcare.staywellsolutionsonline.com/Library/DiseasesConditions/Adult/Liver/90,P01996 Accessed 14.04.2025

 

Last updated: 14 April 2025

GLO-GASTRO-04/2025-02